AAD 2026Abstract 72762RCT
Efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis affecting the nails
A multicenter, randomized, double-blind, placebo-controlled, Phase 3b trial
Yamauchi PS, Kerdel F, Lee MS, Laquer V, Kothekar M, Tripathi A, Nishandar T, Soule BP, Mehta S, Honczarenko M, Sofen HL
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.751 · Not in PubMed: details from Crossref